Wird geladen...
Disease-modifying therapy prescription patterns in people with multiple sclerosis by age
BACKGROUND: Disease-modifying therapies (DMTs) for multiple sclerosis (MS) are approved for their ability to reduce disease activity, namely clinical relapses and signal changes on magnetic resonance imaging (MRI). Disease activity appears age dependent. Thus, the greatest benefit would be expected...
Gespeichert in:
| Veröffentlicht in: | Ther Adv Neurol Disord |
|---|---|
| Hauptverfasser: | , , , , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
SAGE Publications
2021
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8020738/ https://ncbi.nlm.nih.gov/pubmed/33868459 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/17562864211006499 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|